Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation [Phase 1]
NT-175 is being studied in a Phase 1 trial enrolling adults with unresectable, advanced, or metastatic solid tumors positive for HLA-A*02:01…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study [NA]
This clinical trial update describes the PancStrength study, which investigates resistance training to improve physical function in patients…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients [Phase 2]
Phase 2 trial evaluating valproic acid and simvastatin with gemcitabine and nab-paclitaxel regimens in untreated metastatic pancreatic adeno…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial evaluating adding Peposertib (M3814) to radiotherapy for locally advanced pancreatic cancer is currently recruiting (Phase 1/…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer [Phase 1]
Phase 1 clinical trial updates are evaluating combinations of Anetumab Ravtansine with Nivolumab, or with Nivolumab plus Ipilimumab, and wit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial evaluating BMS-986340 as monotherapy and in combination with nivolumab or docetaxel across several advanc…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial studying FOLFIRINOX with elraglusib and losartan in pancreatic adenocarcinoma, including metastatic disease. The st…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 study evaluating the combination of gemcitabine hydrochloride, dasatinib, and erlotinib hydrochloride in patients with metastatic or…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy
A completed multicenter study verifying predictive biomarkers for pancreatic cancer treatment using liquid biopsy.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 clinical trial evaluating NovoTTF-200T(P) in combination with gemcitabine and nab-paclitaxel for resectable pancreatic cancer is c…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: LEE011 Plus Everolimus in Patients With Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of LEE011 (ribociclib) and everolimus in patients with metastatic pancreatic adenocarc…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Alpha Radiation Emitters Device (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer [NA]
A clinical trial exploring the DaRT alpha radiation emitter device in combination with chemotherapy for locally advanced and metastatic panc…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer [Phase 1]
Phase 1 clinical trial evaluating the combination of binimetinib and hydroxychloroquine for KRAS-mutant metastatic pancreatic cancer has com…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma [Phase 3]
A Phase 3 clinical trial evaluating Daraxonrasib alone and in combination with gemcitabine and nab-paclitaxel as first-line therapy for meta…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients With Peritoneal Metastasis From Pancreatic Adenocarcinoma [Phase 1]
A Phase 1 clinical trial is evaluating pressurized intraperitoneal aerosolized chemotherapy (PIPAC) for peritoneal metastasis from pancreati…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC) [Phase 1]
A Phase 1 clinical trial of PTM-101 for pancreatic ductal adenocarcinoma and related locally advanced or borderline resectable disease is cu…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating Acoustic Cluster Therapy (ACT) with chemotherapy for locally advanced pancreatic adenocarcinoma is current…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial of ZM008, an anti-LLT1 antibody, given as a single agent and then in combination with toripalimab in patients with ad…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations [Phase 3]
A Phase 3 study is evaluating chemotherapy with or without panitumumab for unresectable, locally advanced, or metastatic pancreatic cancer w…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement. [NA]
A clinical trial is evaluating the feasibility and safety of combining pancreatic tumor surgery with HIPEC for pancreatic cancer with perito…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 clinical trial from Wake Forest University Health Sciences is evaluating neoadjuvant chemotherapy for borderline resectable and lo…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma [Phase 2]
Phase 2 trial evaluating stereotactic body radiotherapy in combination with a focal adhesion kinase (FAK) inhibitor for advanced pancreatic …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread [Phase 2]
Phase 2 trial update evaluating two regimens for older patients with metastatic pancreatic cancer: gemcitabine plus nab-paclitaxel versus a …
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Anatomical-Clinical Base of Adenocarcinoma Pancreatic
A recruiting clinical trial sponsored by University Hospital, Toulouse, focusing on pancreatic adenocarcinoma.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer [Phase 1]
This first-in-human Phase 1 study investigates an implantable iontophoresis device delivering gemcitabine once weekly or twice weekly for no…